To quantify the frequency of maternal complications associated with cerclage use during pregnancy. STUDY DESIGN: We performed a retrospective population-based cohort study of all singleton live births in Ohio from 2006-2015. Maternal, obstetric and delivery characteristics were compared for births in which cerclage was utilized during the pregnancy versus those without cerclage. The primary outcome for the study was a composite of adverse outcome including maternal intensive care unit (ICU) admission, chorioamnionitis, blood product transfusion, unplanned hysterectomy, and uterine rupture. Secondary outcomes included each of the these individual adverse outcomes as well as maternal transfer to a tertiary facility and unplanned operation after delivery. Multivariate analysis was used to estimate the relative risk of adverse maternal outcomes associated with cerclage placement after adjustment for gestational age and maternal race. RESULTS: Results:Of the 1,401,363 live singleton births in Ohio from 2006-2015, 4,311 (0.3%) were recorded on the birth certificate as having cerclage during pregnancy. Of those, 12.5% experienced an adverse maternal outcome, compared to 2.3% without cerclage. The rate of composite and all individual maternal adverse outcomes were significantly increased for pregnancies with cerclage vs those without, all p0.001 (see Table) . The relative risk (95% CI) for adverse maternal outcome with cerclage is demonstrated in the Figure. After adjustment for gestational age at birth and maternal race, cerclage remained significantly associated with composite adverse outcome, unplanned hysterectomy, maternal transfer to a tertiary care center, uterine rupture, and chorioamnionitis. CONCLUSION: Conclusion: More than 1 in 10 women with cerclage experience a serious maternal adverse outcome, over 5 times higher than the rate in women without cerclage. Even after adjusting for gestational age at delivery, maternal risk remains over 2-fold increased for composite adverse outcome. This information may be helpful in counseling women regarding potential maternal risk when considering neonatal benefit of cerclage in pregnancies at high risk of preterm birth.
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335 Does race affect late preterm neonatal respiratory morbidity?
Maria Andrikopoulou, Eve E. Overton, Sierra J. Seaman, Conrad N. Stern-Ascher, Cynthia Gyamfi-Bannerman Columbia University Irving Medical Center, New York, NY OBJECTIVE: Differences in respiratory disease by race are well described in early preterm infants, but largely unknown for late preterm infants. Our objective was to determine whether neonatal respiratory morbidity differs by race in neonates born late preterm. STUDY DESIGN: Secondary analysis of a randomized trial of women at high risk for late preterm delivery. Our study was limited to women with non-anomalous, singleton gestations delivering between 34+0 to 36+6 weeks. Women were categorized into 4 groups by race: Black, White, Asian, or other/mixed. Primary outcome was a neonatal composite of treatment in the first 72 hours (CPAP or high flow nasal cannula >2 hours, oxygen >4 hours, ECMO or mechanical ventilation) or stillbirth or neonatal death before 72 hours. Secondary outcomes include major respiratory morbidity (MRM, the primary outcome, extending CPAP or high-flow nasal cannula to >12 continuous hours and oxygen to at least 24 continuous hours) and other outcomes listed in Table 1 . The primary and secondary outcomes were assessed in the active and placebo groups separately, and the full cohort was assessed for treatment interaction with race. We fit a logistic regression model to adjust for confounders related to respiratory morbidity. RESULTS: Of 2,331 included women, 26.9% (n¼ 627) were Black/ African American, 57.1% White (n¼1333), 3.56% Asian (n¼83) and 12.36% (n¼288) were other/mixed. In the placebo group the rate of the primary outcome was significantly higher in Whites (18.6%) and Asians (22.8%) compared to the African American/Black group (12.3%) (p 0.03) (table 1). Adjusting for confounders, Black infants still had lower but non-significant rates of the primary outcome. The primary predictor for respiratory morbidity was a prior pregnancy with neonatal respiratory morbidity. Findings were similar in the steroid group (Table 1) , but MRM was less common in black compared with white infants (aOR 0.45, 95%CI 0.24, 0.83) (table 2) . However, a prior pregnancy with neonatal respiratory complications was no longer associated with respiratory morbidity after receipt of betamethasone. Assessing the full cohort, there were no significant interactions between steroids and race. CONCLUSION: Late term respiratory morbidity is lower in black infants and reduced further by steroid administration. While history of pregnancy with previous neonatal respiratory disease is the strongest risk factor for recurrence, this risk factor was mitigated by receipt of steroids.
